Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Considered the newest GLP-1based therapy on the horizon, retatrutide is a triple receptor agonist that targets GLP-1, GIP, and glucagon receptors
For example, a decreased libido is a common side effect of hormone-altering medications like antidepressants, anti-anxiety medications, and birth control
Research Applications Gastrointestinal: Ulcer repair, gut lining integrity modelling, and IBD pathway research
Also contraindicated in pregnancy and lactation, and in individuals with bleeding disorders
US$ 26.58
US$ 27.08
US$ 26.41
US$ 25.19
US$ 22.43
US$ 21.79
US$ 23.88
